XRAY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DENTSPLY SIRONA Inc (XRAY) is not a strong buy for a beginner, long-term investor at this time. The company's recent financial performance shows declining profitability, and its technical indicators suggest a bearish trend. While analysts have raised price targets and some see stabilization in the dental market, the elimination of dividends and lack of strong trading signals make this stock less appealing for immediate investment. A hold position is recommended until clearer growth signals emerge.
The MACD is negatively expanding below zero, indicating bearish momentum. The RSI is neutral at 39.648, and moving averages are converging, showing no clear trend. The stock is trading near its support level of 12.421, with resistance at 14.396. Overall, the technical indicators suggest a bearish to neutral trend.
Analysts have raised price targets, and some see evidence of stabilization in the dental market. Revenue grew 6.19% YoY in Q4 2025, and the company has announced a 'Return to Growth' plan.
The company eliminated its dividend, which may deter income-focused investors. Net income dropped by 66.05% YoY, and EPS declined by 66.20%. Gross margin also fell by 8.31%. Technical indicators and trading sentiment are weak, with no significant hedge fund or insider activity.
In Q4 2025, revenue increased by 6.19% YoY to $961 million, but net income dropped by 66.05% to -$146 million. EPS fell by 66.20% to -$0.73, and gross margin declined to 46.1%, down 8.31% YoY.
Analysts have raised price targets, with the highest being $18. The ratings range from Buy to Neutral, with some firms noting stabilization in the dental market. However, the elimination of dividends and ongoing challenges limit the stock's appeal.
